Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2024 Results Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights • Revenue of $307.2 million • Net loss of $31.0 million • Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: • Revenue expected in a range of $1.4 billion to $1.5 billion • Net loss expected in a range of $42 million to $6 million • Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment ...

4 th Quarter Fiscal 2024 | We shop. You save. Earnings Conference Call Presentation September 13, 2024 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR 6800 West 115th Street Suite 2511 66211 Overland Park Kansas (Zip Code) (Address of principal executive offices) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) ...

Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants SelectQuote, Inc. (NYSE:SLQT) Q3 2024 Results Conference Call May 9, 2024 9:00 AM ET Hello, all, and welcome to SelectQuote's Fiscal Third Quarter Earnings Conference Call. [Operator instructions]. Matt Gunter And finally, a reminder that certain statements made today may be forward-looking statements. These statements are made b ...

Exhibit 99.1 SelectQuote, Inc. Reports Third Quarter 2024 Results Third Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights • Revenue of $376.4 million • Net income of $8.6 million • Adjusted EBITDA* of $46.6 million Raising Fiscal Year 2024 Guidance Ranges: • Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion • Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million • Adjusted EBITDA* expect ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...

Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Matt Gunter As referenced on Slide 2, during this call, we will be discussing some non-GAAP financial measures. The most directly comparable GAAP financial measures and a reconciliation of the differences between the GAAP and non-GAAP financial measures are available on our earnings release and investor presentation on our website. And finally, a reminder th ...

*See "Non-GAAP Financial Measures" above on slide 2. $90 $MM | We shop. You save. MA LTV | We shop. You save. 8 LTM 9/30/22 LTM 9/30/23 9 60,000 $MM | We shop. You save. l | | l $37 $38 $7 $9 Life Auto & Home 1Q23 1Q24 $5 $5 $2 $3 Life Auto & Home 1Q23 1Q24 11 12 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------|-------|--------|-------|----------------------|-------|------------|-------------|-------|--------- ...

Financial Data and Key Metrics - The company achieved stable and strong profitability in Q1 2024, marking seven consecutive quarters of improved operating results across all business segments [18] - Consolidated revenue for Q1 2024 was $233 million, with adjusted EBITDA at negative $11 million, representing a year-over-year improvement of over $16 million compared to Q1 2023 [54] - SelectRx surpassed 52,000 members, with healthcare services revenue exceeding senior revenues for the first time in company history [19] - Senior distribution business grew revenue by 16% year-over-year, with MA approved policies increasing by 17% to 98,000 [29][63] - Life and Auto & Home segments combined revenues were $47 million, up nearly 7% year-over-year, with adjusted EBITDA totaling nearly $9 million [47][44] Business Line Performance - SelectRx membership grew by over 60% year-over-year, reaching 52,000 members, driven primarily by Medicare Advantage interactions [67] - Healthcare services revenue grew by 50% year-over-year, driven by the maturation of the membership base and increased full-box utilization [5] - Senior distribution business saw a 22% decline in operating expense per policy, a 30% improvement in marketing expense per policy, and a 25% increase in agent close rates year-over-year [65] - Life business benefited from the adoption of the SwiftTerm Select product, while Auto & Home remained stable despite a challenging P&C insurance market [47] Market Performance - The company is well-positioned to serve all 50 states, with a single pharmacy system that is more efficient and integrated with automated fulfillment and shipping functions [58] - The Medicare Advantage market continues to show strong demand, with over 4 million Americans turning 65 each year, providing a long-term growth opportunity [40] - The company has seen deeper coordination with carriers, improving onboarding experiences and retention behavior [22] Strategic Direction and Industry Competition - The company’s strategy focuses on tenured agents, high-quality leads, and advanced technology tools to drive efficiency and policyholder persistency [20][21] - SelectRx is seen as a key differentiator, with the platform enabling differentiated customer acquisition and engagement, positioning the company at an advantageous intersection in the healthcare ecosystem [59] - The company is exploring additional market opportunities to leverage its platform for delivering value in the healthcare ecosystem [60] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the company’s preparation for the AEP and OEP seasons, with early results aligning with expectations [53] - The company expects to achieve attractive EBITDA margins in the low 20s for the senior distribution business in fiscal 2024 [32] - Management highlighted the importance of the healthcare services segment in offsetting seasonal expenses and driving future profitability [28] Other Important Information - The company emphasized its unique value proposition, combining Medicare Advantage distribution with tailored prescription drug delivery to drive higher patient medication adherence [25] - SelectRx’s revenue per member per month is more than 35% higher than the prior business, reflecting improved unit economics [24] - The company’s tenured agent retention remains strong, providing a key strategic advantage in the competitive Medicare Advantage market [55] Q&A Session Summary Question: Impact of regulatory changes on AEP performance - The company noted that regulatory changes, such as the 48-hour rule, had some impact but were in line with expectations, with no significant disruptions observed [34][69] - Management highlighted that the company’s alignment with carriers and focus on high-adherence solutions has been well-received, contributing to positive persistency and adherence metrics [77][71] Question: Growth trajectory and operational readiness for SelectRx - Management expressed confidence in SelectRx’s growth trajectory, expecting membership growth of 25% and healthcare services revenue growth of 50% for the year [5] - The company has scaled operations effectively, with customer satisfaction and NPS scores being strong indicators of operational readiness [70] Question: Outlook on P&C insurance market - The company acknowledged the challenging P&C insurance market but noted that carriers are adjusting underwriting practices, with the business continuing to perform well [80] Question: EBITDA cadence for fiscal 2024 - Management expects the EBITDA cadence to follow historical patterns, with healthcare services projected to achieve low single-digit EBITDA margins, improving as the business scales [74] Question: Plan design and shopping behavior - Management observed that plan features this year are similar to last season, with carriers focusing on maintaining critical consumer benefits, leading to stable shopping behavior [86][92]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section ...